Coagulation Factor IX Human

DB13152ApprovedInvestigationalProtein Based TherapiesBlood Coagulation FactorsHemostatics

Coagulation Factor IX Human is a coagulation factor used to treat hemophilia B or factor IX hemophilia. Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.

Protein structure of Coagulation Factor IX Human
Mechanism
Curator reviewed
Primary indication
Factor IX is used to treat Christmas disease.Curator reviewed · 3 structured indications
Formula / weight
C2041H3136N558O641S25 · 46548.2 Da
First approval
Canada, 2007 · United States, 1990
Also known as
Antihemophilic factor B · Coagulation factor IX (human) · Factor IX (Human) · Human coagulation factor IX
Brand names
  • Alphanine Sd
  • Balfaxar
  • Beriplex
  • Immunine Vh
  • Kcentra
  • Octaplex

Resolves to

What you can answer from here — as of June 15, 2026

7Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
90Drug interactionsStructured to mechanism, not free text
Sign in
45Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
129Marketed productsAcross 9 countries and 37 labellers
Sign in
2ATC codesIncluding every combination product, plus 12 drug categories
Sign in
33+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Coagulation Factor IX Human, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account